Biosynthetic insulin used as injectable medication.
1Background: Many patients with diabetes require insulin therapy to achieve optimal glycemic control.
2Conclusions: The clinical outcomes of T2DM patients improved after insulin therapy was started.
3Objectives: Adherence to insulin therapy can be threatened by pain and needle fear.
4The advantage of insulin therapy for diabetic patient with hypertension is still controversial.
5Furthermore, her blood glucose level is well controlled with insulin therapy.
6The remaining 3 patients exhibiting NETs and DM-II had been treated with insulin therapy.
7Objective: The role of intensive insulin therapy in medical surgical intensive care patients remains unclear.
8In view of this anti-inflammatory effect, long-term insulin therapy may potentially have an anti-atherogenic effect.
9Intensive insulin therapy might be necessary in such cases.
10After surgery, adrenal function was normal and insulin therapy was again necessary to control diabetes.
11Interventions: Pump or MDI structured training in flexible insulin therapy, followed up for 2 years.
12The gold standard mode of insulin therapy in this view is CSII using fast-acting analogues.
13It may be one of the mechanisms through which insulin therapy improves peripheral insulin resistance.
14However, in many intervention studies, the intensive insulin therapy provided promising effects on preventing cardiovascular disease.
15Patients with new onset of diabetes needed insulin therapy, even in the maintenance therapy of AIP.
16These values decreased after insulin therapy was started.
Translations for insulin therapy